Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.
Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):93-109. eCollection 2019.
Am J Nucl Med Mol Imaging. 2019.
PMID: 30911439
Free PMC article.